ReAble to start roadshow Wednesday for $575 million eight-year notes

By Paul A. Harris

St. Louis, Oct. 30 - ReAble Therapeutics Inc. will start a roadshow on Wednesday for its $575 million offering of eight-year senior notes (Caa1), according to an informed source.

The Rule 144A deal, which is being led by Credit Suisse and Banc of America Securities LLC, is expected to price late next week.

The notes will come with four years of call protection.

Proceeds will be used to help fund the acquisition of DJO Inc.

ReAble is an Austin, Texas, medical device company focused on rehabilitation, pain management, physical therapy and orthopedics.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.